10 completed. 10 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 10 |
| Phase 2 | 4 | Completed 4 |
Follow Glomerulonephritis, Membranous: new trials by email Literature Review of Glomerulonephritis, Membranous trials Research Report on Glomerulonephritis, Membranous
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy TACROLIMUS, RITUXIMAB, METHYLPREDNISOLONE - MEMBRANOUS NEPHROPATHY | Phase 3 | Completed | Hospital Universitario 12 de Octubre | 86 | 2014-01-01 | 2020-01-18 |
| Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin), experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab) - Idiopathic Membranous Nephropathy | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 80 | 2012-01-17 | 2021-10-26 |
| MEmbranous Nephropathy Trial Of Rituximab Rituximab, Cyclosporine - Idiopathic Membranous Nephropathy | Phase 2 / Phase 3 | Completed | Mayo Clinic | 130 | 2011-11-01 | 2019-04-30 |
| Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy Mycophenolate mofetil, low dose steroid, Cyclosporin, low dose steroid - Glomerulonephritis, Membranous | Phase 3 | Completed | Kyungpook National University Hospital | 43 | 2011-03-01 | 2025-08-27 |
| A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis prednisolone and mycophenolate mofetil, prednisolone and tacrolimus - Lupus Nephritis, Glomerulonephritis, Membranous | Phase 3 | Completed | Hospital Authority, Hong Kong | 20 | 2005-11-01 | 2013-10-23 |
| Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome tacrolimus combined with prednisone - Idiopathic Membranous Nephropathy, Nephrotic Syndrome | Phase 2 / Phase 3 | Completed | Peking University | 2004-11-01 | 2006-08-10 | |
| Rituximab in Membranous Nephropathy Rituximab - Membranous Nephropathy | Phase 2 / Phase 3 | Completed | Mayo Clinic | 15 | 2004-08-01 | 2011-02-25 |
| Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental prednisolone and mycophenolate mofetil, prednisolone and chlorambucil - Glomerulonephritis, Membranous, Glomerulosclerosis, Focal | Phase 3 | Completed | Hospital Authority, Hong Kong | 16 | 2003-01-01 | 2013-10-23 |
| Mycophenolate Mofetil in Membranous Nephropathy mycophenolate mofetil orally 1000 mg twice a day (BID), prednisone 0,5 mg/kg orally on alternate days, intravenous (i.v.) methylprednisolone 1000 mg, total 9 - Glomerulonephritis, Membranous | Phase 2 / Phase 3 | Completed | Radboud University Medical Center | 30 | 2002-05-01 | 2005-12-06 |
| Treatment of Patients With Idiopathic Membranous Nephropathy Cyclophosphamide and steroids - Glomerulonephritis, Membranous | Phase 3 | Completed | Radboud University Medical Center | 29 | 1997-07-01 | 2014-01-28 |
Glomerulosclerosis, Focal Segmental (1) · Lupus Nephritis (1) · Nephrotic Syndrome (1) · Proteinuria (1)
Autoimmune Diseases (10) · Female Urogenital Diseases (10) · Female Urogenital Diseases and Pregnancy Complications (10) · Glomerulonephritis (10) · Immune System Diseases (10) · Kidney Diseases (10) · Male Urogenital Diseases (10) · Nephritis (10) · Urogenital Diseases (10) · Urologic Diseases (10) · Connective Tissue Diseases (1) · Lupus Erythematosus, Systemic (1) · Nephrosis (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Rituximab (4) · Mycophenolic Acid (3) · Prednisolone (3) · Cyclophosphamide (2) · Cyclosporine (2) · Methylprednisolone (2) · Steroids (2) · Tacrolimus (2) · Adrenergic beta-Antagonists (1) · Angiotensin II (1) · BID protein, human (1) · Chlorambucil (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Prednisone (1)
Hospital Authority, Hong Kong (2) · Mayo Clinic (2) · Radboud University Medical Center (2) · Assistance Publique - Hôpitaux de Paris (1) · Hospital Universitario 12 de Octubre (1) · Kyungpook National University Hospital (1) · Peking University (1)
China (2) · Netherlands (2) · United States (2) · Canada (1) · France (1) · South Korea (1) · Spain (1)
Daniel TM Chan, Prof (2) · Fernando C. Fervenza, M.D., Ph.D. (2) · Fanfan Hou, MD (1) · Feifei Xu, MD (1) · Fuming Lu, MD (1)
PMID 34778952, PMID 17660026, PMID 19666912, PMID 26087670, PMID 27352623, PMID 29441742, PMID 31269364, PMID 31340979, PMID 32231244, PMID 35224732